STAAR Surgical Co Debt Securities, Available-for-sale, Unrealized Loss
STAAR Surgical Co (STAA) reported Debt Securities, Available-for-sale, Unrealized Loss of $13.00 thousand for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2026-08-12
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for the quarter ending 2026-07-03 was $7.00K.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for the quarter ending 2026-04-03 was $6.00K, a 64.71% decline year-over-year.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for the quarter ending 2026-01-02 was $1.00K, a 95.00% decline year-over-year.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for the quarter ending 2025-09-26 was -$3.00K.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for fiscal 2024 was $32.00K, a 54.29% decline from fiscal 2023.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for fiscal 2023 was $70.00K, a 84.20% decline from fiscal 2022.
- STAAR Surgical Co debt securities, available-for-sale, unrealized loss for fiscal 2022 was $443.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month | Debt Securities, Available-for-sale, Unrealized Loss 9 month | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2026-07-03 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $13.00K 10-Q · filed 2026-08-12 | $14.00K derived: sum of 3 quarters · filed 2026-08-12 | $11.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $6.00K 10-Q · filed 2026-05-13 | $7.00K derived: sum of 2 quarters · filed 2026-08-12 | $4.00K derived: sum of 3 quarters · filed 2026-08-12 | -$8.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $1.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-12 | -$2.00K derived: sum of 2 quarters · filed 2026-08-12 | -$14.00K derived: sum of 3 quarters · filed 2026-08-12 | $3.00K 10-Q · filed 2026-08-12 |
| 2025-09-26 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$15.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.00K 10-Q · filed 2025-11-05 | $22.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-06-27 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $5.00K 10-Q · filed 2025-08-06 | $25.00K derived: sum of 3 quarters · filed 2026-03-03 | -$41.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2025-03-28 | $17.00K 10-Q · filed 2025-05-07 | $37.00K derived: sum of 2 quarters · filed 2026-03-03 | -$29.00K derived: sum of 3 quarters · filed 2026-03-03 | -$37.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-12-27 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$46.00K derived: sum of 2 quarters · filed 2026-03-03 | -$54.00K derived: sum of 3 quarters · filed 2026-03-03 | $32.00K 10-K · filed 2026-03-03 |
| 2024-09-27 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$74.00K derived: sum of 2 quarters · filed 2024-10-30 | $12.00K 10-Q · filed 2024-10-30 | -$207.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-06-28 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $78.00K 10-Q · filed 2024-08-07 | -$141.00K derived: sum of 3 quarters · filed 2025-02-21 | -$289.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-03-29 | $86.00K 10-Q · filed 2024-05-07 | -$133.00K derived: sum of 2 quarters · filed 2025-02-21 | -$281.00K derived: sum of 3 quarters · filed 2025-02-21 | -$186.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-12-29 | -$219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$367.00K derived: sum of 2 quarters · filed 2025-02-21 | -$272.00K derived: sum of 3 quarters · filed 2025-02-21 | $70.00K 10-K · filed 2025-02-21 |
| 2023-09-29 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$53.00K derived: sum of 2 quarters · filed 2023-11-06 | $289.00K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $437.00K 10-Q · filed 2023-08-02 | ||
| 2023-03-31 | $342.00K 10-Q · filed 2023-05-03 | |||
| 2022-12-30 | $443.00K 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |